Precise action anti-cancer drugs in the cell clarified
Watching a drug in action.
10 Dec 2019 ⋅ Nature Materials
Machine learning decreases experimental costs of drug combination screening for translational applications
FIMM researchers have developed an efficient machine learning model that requires only a limited set of dose-response measurements for accurate prediction of drug combination synergy in a given patient sample. The minimal-input web-implementation, named DECREASE, supports cost-effective combinatorial screening in precision medicine projects with decreased experimental costs, translational time and number of patient-derived cells required.
9 Dec 2019 ⋅ Nature Machine Intelligence
Formation of the Global Frankincense Alliance
The process of co-creating the Global Frankincense Alliance (GFA ) has been initiated by a group of committed people from industry, trade and academia dedicated to the propagation, conservation and sustainable harvesting of frankincense, myrrh and associated plant species.
5 Dec 2019 ⋅ World Congress of Medicinal and Aromatic Plants (WOCMAP 2019)
Cutting nanoparticles down to size – new study
A new technique in chemistry could pave the way for producing uniform nanoparticles for use in drug delivery systems.
27 Nov 2019 ⋅ Nature Communications
Omega-3 shows protection against heart disease-related death, without prostate cancer risk
Researchers continue to research the potential benefits and risks of this popular supplement, especially when it comes to prostate cancer risk and heart health.
17 Nov 2019 ⋅ 2019 American Heart Association Scientific Sessions
Drug discount cards could actually cost patients more
Brand discount cards have become a popular way for patients to reduce out-of-pocket spending on drugs; however, controversy exists over their potential to increase insurers’ costs.
16 Nov 2019 ⋅ Canadian Medical Association Journal